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Polymeric films associating different concentrations of Eudragit® FS 30 D (EFS) and chondroitin sulfate 
(CS) were produced by casting for the development of a new target-specific site material. Formed films 
kept a final polymer mass of 4% (w/v) in the following proportions: EFS 100:00 CS (control), EFS 95:05 
CS, EFS 90:10 CS and EFS 80:20 CS. They were analyzed for physical and chemical characteristics 
using Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and Raman 
spectroscopy. Furthermore, they were characterized by their water vapor permeability and degree of 
hydration at different conditions simulating the gastrointestinal tract. No chemical interactions were 
observed between CS and EFS, suggesting only a physical interaction between them in the different 
combinations tested. The results suggest that EFS and CS, when combined, may form films that are 
candidates for coating processes seeking a modified drug delivery, especially due to the synergism 
between pH dependency and specific biodegradability properties by the colonic microbiota. EFS 90:10 
CS proved to be the most suitable for this purpose considering hydration and permeability characteristics 
of different associations analyzed. 
Uniterms: Polymeric films/smelting process. Eudragit® FS 30 D/modified delivery. Chondroitin Sulfate. 
Polymeric coating. 
INTRODUCTION
The delivery of oral drugs in the colonic region 
is valuable in the treatment of diseases that affect this 
intestinal segment. It is possible to achieve a high 
concentration of drug while reducing side effects. 
Among the diseases that could benefit from this strategy, 
Crohn’s disease, colon carcinoma, ulcerative colitis and 
inflammatory bowel disease can be mentioned (Kumar, 
Chandra, Gautam, 2013). Furthermore, it is believed 
that the colonic region also provides an improved 
availability for drugs that are poorly absorbed in the upper 
gastrointestinal tract, such as peptides and proteins, which 
has created in recent years a considerable interest for the 
segmentation of drugs in this intestine portion (Pinto, 
2010; Zimová et al., 2012; Kumar, Chandra, Gautam, 
2013). One of the existing systems for modified delivery 
of drugs in specific sites of the gastrointestinal tract 
(GIT), including the colon (pH 6.4 - 7.0), is based on the 
exploitation of the local pH. For this, many pH-dependent 
polymer coatings have been used (Pinto, 2010; Kumar, 
Chandra, Gautam, 2013; Bunhak, et al., 2015). Eudragit® 
FS 30 D stands out as one of these polymers, whose 
dissolution occurs at a pH above 7.0, and thus can be 
used in a drug delivery system designed for the terminal 
portion of the GIT (Pinto, 2010; Zimová et al., 2012). 
The main problem associated with this type of delivery 
system is GIT pH changes arising from pathophysiological 
conditions and individual variations, which may influence 
drug delivery (Bunhak et al., 2015). 
Faced with this problem, the use of natural non-
cellulosic hydrophilic polysaccharides, particularly 
when considering the specific biodegradability by the 
anaerobic microbiota found in distal areas of the GIT, 
has aroused great interest among researchers (Souto-
Maior et al., 2010; Ramasamy et al., 2012). In addition 
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to this favorable characteristic, natural polymers are 
found in abundance, they have low toxicity, low cost and 
flexibility to chemical modification, making them suitable 
for use in pharmaceutical coatings (Amrutkar, Gattani, 
2009). Chondroitin sulfate is a natural polymer studied 
as a carrier of drugs in the research and development 
of new therapeutic systems designed for controlled and 
site-specific delivery (Bunhak et al., 2015; Amrutkar, 
Gattani, 2009). It can be found in bones, cartilages and 
connective tissues. It is comprised of acetylgalactosamine 
and alternating residues of glucuronic acid (Huang et al., 
2010).
Because the GIT colonic region has a wide range of 
anaerobic microorganisms producing enzymes potentially 
capable of degrading polysaccharides, including 
chondroitin sulfate, the use of controlled drug delivery 
systems activated by the microbial flora in this region is 
considered as most promising, as they provide a greater 
specificity in the kinetics of drug delivery (Bunhak et al., 
2015; McConnell, Short, Basit, 2008; Rabito et al., 2012). 
From the combination of pH dependence and 
specific biodegradability mechanisms by the colonic 
microbiota, we seek through this study to characterize the 
behavior of films of Eudragit® FS 30 D associated with 
different chondroitin sulfate concentrations hopping the 
development of a new material for modified drug delivery. 
Therefore, tests were conducted to assess the degree of 
hydration and permeability of films in order to ascertain 
degradation perspectives by the colonic microbiota and 
drug release, respectively (Cavalcanti et al., 2002; Bunhak 
et al., 2007a; Melo et al., 2010). Physical and chemical 
tests were performed involving Fourier transform infrared 
spectroscopy (FTIR), Scanning Electron Microscopy 
(SEM) and Raman spectroscopy with the purpose of 
observing the morphology of the formed films and the 
possible interactions among polymers in the associations. 
MATERIAL AND METHODS
Material
Eudragit® FS 30 D (CAS: 26936-24-3, Evonik, 
Germany), chondroitin sulphate (Solabia-Brazil), 
simulated gastric fluid (SGF; pH 1.2) and simulated 
intestinal fluid (SIF; pH 6.8) prepared according to the 
23st ed. Pharmacopoeia of the United States of America 
(USP 23), Tween® 80 (CAS: 9005-65-6, Aldrich, United 
States), glyceryl monostearate (CAS: 123-94-4, Fluka, 
Switzerland), sodium hydroxide (CAS: 1310-73-2, Vetec, 
Brazil), glacial acetic acid (CAS: 758-12-3, Sinth, Brazil), 
potassium chloride and potassium phthalate monobasic 
(CAS: 877-24-7, Nuclear, Brazil). All reactants possess 
analytical grade and were used without further purification.
METHODS
Preparation of the films
The films were obtained using the conventional 
method for thermoplastic and thermosetting polymers 
known as “casting process” (Bunhak et al., 2007b; Braz, 
Hechenleitner, Cavalcanti, 2007; Santos et al., 2013; 
Souto-Maior et al., 2010). For the preparation of the 
films, an aqueous dispersion of the synthetic polymer 
Eudragit® FS 30 D (EFS) was used associated with the 
polysaccharide chondroitin sulfate (CS) in the proportions 
(w/w)%: 100:0 (control), 95:05, 90:10 and 80:20, while 
maintaining a final polymer concentration at 4% (w/v). 
EFS was initially stirred with glyceryl monostearate 
(previously prepared in emulsion at 5% polysorbate 80) 
at 50 °C for 30 minutes. Subsequently, the CS dissolved 
in distilled water was slowly added to the dispersion 
containing EFS, and the mixture was subjected to 
magnetic stirring. All dispersions were made using a 
vacuum pump during the homogenization process to avoid 
air incorporation and the undesirable formation of bubbles 
in the polymeric mixture. The final dispersion was poured 
into Teflon® molds in 10 mL samples, which were kept in 
an incubator at 50 ± 2 °C for 24 hours. 
Fourier transform infrared spectroscopy (FTIR)
In order to characterize the synthetic polymer and the 
polysaccharide and to establish the possible interactions 
between them in the associations, a spectroscopic analysis 
in the infrared region was carried out using a Vertex 70v 
Bruker, performing a reading in the spectral range 4,000-
400 cm-1 with a resolution of 4 cm-1 and 100 scans.
Raman spectroscopy
Raman spectroscopy has been widely used in 
the characterization of drug delivery systems. By this 
technique, among other applications, it is possible to 
understand drug-excipient and drug-polymer interactions 
in the formulation, characterize the primary coating 
material and verify the homogeneity of distribution of the 
active ingredient in a formulated compound pill, using for 
this purpose Raman chemical imaging (Paudel, Raijada, 
Rantanen, 2015; Smith et al., 2015). The assay was 
performed with a micro-Raman SENTERRA spectrometer 
(Bruker Corporation, Germany). Polymer films were 
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analyzed at a wavelength of 1,064 nm for the FT-Raman 
spectroscopy, covering regions between 4,000 and 400 
cm-1, and 785 nm for mapping.
Determination of the film swelling index
The determination of the swelling index was made 
in order to know the degree of hydration of films formed 
upon contact with the simulation of physiological fluids of 
the gastrointestinal tract. For this, the films were cut using 
surgical scissors in 1 cm2 samples and placed in Petri dishes. 
The total losses of residual moisture from different film 
samples were made in an oven at 40 °C for approximately 
24 hours. The dried films were weighed and immersed in 
a medium containing SGF (pH 1.2) and SIF (pH 6.8) at 
37±0.5 °C for certain time periods (1, 3, 5, 7, 10, 30, 60, 
90, 120 and 180 min). After the pre-determined intervals 
for film hydration, they were carefully removed from the 
medium in which they were immersed and the excess of 
water was removed. Then, they underwent a new weighing. 
The swelling index was given by the Eq. (1), where Sw is 
the Swelling index, Ws and Wd is the weight of Swollen and 
Dry film, respectively (Souto-Maior et al., 2010).
  Eq. (1)
Water vapor transmission
The analysis of water vapor transmission (WVT) 
was performed according to the method “B” of the ASTM 
(American Society for Testing and Materials) designated 
as E 96-66. The assay was performed in triplicate for each 
association: EFS 100:00 CS, EFS 95:05 CS, EFS 90:10 
CS and EFS 80:20 CS. Films with a 10 cm² area were 
fixed in permeability cups (Braive Instruments, Liege, 
Belgium) containing 10 mL of distilled water. This set 
was weighed and then placed in a desiccator containing 
dried silica gel, which was kept at room temperature and 
humidity. After the pre-established times (24, 48, 72, 96 
and 120 hours), the set was again weighed and the silica 
gel was replaced at each interval by a new dehydrated 
silica gel. The readings of the weight lost by the cups in the 
respective intervals were recorded and used to calculate 
water vapor transmission rate according to Eq. (2), where 
g is lost weight, t is time in hours during which the weight 
loss was observed, and a represents the area of the film 
(Souto-Maior et al., 2008).
  Eq. (2)
Scanning electron microscopy
The morphological characterization of polymeric 
films was performed using scanning electron microscopy 
(SEM). Samples of isolated films in the proportions 100:00 
and 90:10, both dried and after 60 minutes of immersion 
in SGF (pH 1.2) and SIF (pH 6.8), were frozen at -18 °C 
with liquid nitrogen and lyophilized at -55 °C/6 h in a 
Liotop® L101 lyophilizer (Liobras®). Subsequently, the 
samples were metallized with gold in a Shimadzu IC-
50 equipment and micrograph images of the fractured 
surfaces of polymer films were obtained with a scanning 
electron microscope Shimadzu® SS-550 operated at 10 
keV (Rabito et al., 2012).
RESULTS AND DISCUSSION
FTIR
EFS 100:00 CS composition films analyzed by 
FTIR revealed EFS characteristic bands at 1726 cm-1 
corresponding to the C=O vibrations of carboxylic 
groups esterified, at 1164 cm-1 and 1198 cm-1 due to ester 
vibrations and in the range between 2500-3500 cm-1 related 
to the absorption of OH- groups. The other combinations 
containing 5%, 10% and 20% of CS were similar to 
the control. In the upper spectral region, at 3000 cm-1, 
there was a greater intensity of bands proportional to 
the addition of CS, which may be associated with the 
OH- group common to both CS and EFS (Evonik, 2015; 
Amrutkar, Gattani, 2009). When comparing the spectrum 
of the control film and spectra of films associated with 
CS, the non-appearance of new bands can be verified, 
except CS absorption bands. Rabito et al. (2012) observed 
similar results working with Eudragit® FS 30 D and 
arabinoxylane films: likewise, the appearance of new 
bands was not noticed. Thus, there were only physical 
interactions between the compounds (Rabito et al., 2012). 
FTIR data corroborate Raman spectroscopy data. FTIR 
spectra of control films and other associations can be seen 
in Figure 1.
Raman spectroscopy
Chemical images of polymer films provided 
by Raman spectroscopy showed the homogeneous 
incorporation of the natural CS polysaccharide to the 
synthetic polymer EFS. As observed in Figure 2, the 
increase in the CS concentration resulted in a higher 
intensity of pink-reddish tint, suggesting a greater 
incorporation with the EFS-based polymer. 
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Raman spectra showed a characteristic peak of 
CS at 1063 cm-1 in EFS films associated with CS, which 
is characteristic of the symmetrical stretching of the 
grouping SO3–, becoming better evidenced with the 
addition of the polysaccharide (Lim et al., 2011; Esmonde-
White et al., 2011). The spectrum of a chemical compound 
provided by Raman spectroscopy has been referred to as 
the compound fingerprint. This characterization provided 
by this technique has been very useful in identifying 
several chemical compounds, including those with a high 
degree of complexity (Kudelski, 2008). As the spectra of 
films did not reveal the emergence or extinction of Raman 
peaks, it is suggested that the addition of the natural 
polysaccharide did not change the chemical structure of 
the EFS (Figure 3).
Determination of the film swelling index
The swelling index (Sw%) was the parameter 
used to assess the degree of hydration of polymer films. 
As shown in Figure 4, the swelling of the films was 
proportional to the pH value and the concentration of 
CS. The influence of pH is due to the pH dependence 
of the EFS-based polymer, whose dissolution occurs at 
a pH higher than 7.0, thus justifying the higher Sw% in 
SIF. Regarding the polysaccharide, the increase in its 
concentration promoted a higher degree of hydration 
of films, both immersed in SGF and SIF. However, in 
both fluids, there was a partial disintegration of films 
combined with 20% of CS, causing a false decrease in the 
Sw%, particularly in SGF. Bunhak et al. (2007a) found 
a similar behavior upon studying the influence of CS on 
the formation of ethyl cellulose films. Disintegration 
was also observed in films composed of 20% of CS. The 
author attributed this to the high water solubility of the 
natural polysaccharide.
The hydration of the films is a factor of interest 
and concern. In the first case, it is an essential aspect to 
degradation by colonic microbiota (Bunhak et al., 2007a). 
In contrast, the increased Sw% may cause premature 
delivery of the drug (Pinto, 2010). We can thus infer that 
the EFS 90:10 CS combination film is the candidate most 
appropriate for the development of coatings seeking a 
modified drug delivery. 
Water vapor transmission (WVT)
The permeability of polymer films was measured 
by the water vapor transmission rate (Joshi, Petereit, 
2013). Figure 5 shows the average values of the WVT 
rate in function of CS concentration and time. The 
highest concentration of the polysaccharide promoted an 
increase in the WVT, which may be associated with the 
hydrophilicity provided by CS. Souto-Maior et al. (2010) 
observed a similar behavior upon preparing Eudragit® 
RS 30 D films associated with phosphated pectin and 
FIGURE 1 - FTIR spectra of EFS 100:00 CS (control) and of the associations containing 5%, 10% and 20% of CS. EFS Eudragit® 
FS 30, CS Chondroitin sulfate.
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FIGURE 2 - Raman chemical imaging of the EFS 100:00 CS (1.), EFS 95:05 CS (2.), EFS 90:10 CS (3.) and EFS 80:20 CS (4.) 
composition films. The intensity scale to the right indicates the quantity of chondroitin sulfate, wherein the minimum (zero) indicates 
absence of the natural polysaccharide. 
Bioecolians® prebiotic oligosaccharide. The increase 
in phosphated pectin caused a greater WVT rate when 
compared to the control film composed only of Eudragit® 
RS 30 D. The author attributed this phenomenon to the 
hydrophilicity related to the addition of the polysaccharide. 
Bunhak et al. (2007b), using Eudragit® RS 30 D associated 
with CS, also found similar results for permeability, 
which showed a proportional relation to the increase in 
polysaccharide concentration. 
Scanning electron microscopy
Scanning electron microscope (SEM) was performed 
only with the control composition (EFS 100:00 CS) and 
with the composition containing 10% of CS (EFS 90:10 
CS), since the latter proved to be the most suitable for the 
development of coatings aimed at a modified delivery 
of drugs, according to the results found by the swelling 
index assay.
From the analysis of micrographs (Figure 6), it was 
observed that the control film (EFS 100:00 CS) in SGF 
showed insignificant changes in the polymeric mesh when 
compared to the dry assay. Compared to the control in 
SIF, which can be seen in the study by Lima (2013), there 
is a slight modification of the polymer mesh, which is 
associated with the pH dependence of EFS. This does not 
occur when comparing EFS 90:10 CS composition films 
immersed in SGF and SIF. In SGF, there is a superficial 
breakdown of the polymer mesh, probably related to an 
increase in hydrophilicity associated with the presence of 
CS. However, this breakdown is more significant in SIF 
because of the pH dependency of EFS combined with the 
hydrophilic characteristic of the polysaccharide (Lee et 
al., 2015). Morphological changes recorded with SEM 
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reveal the influence of CS on changing film properties, 
agreeing with the results obtained in Swelling Index and 
water vapor transmission studies.
CONCLUSION
The results suggest that the synthetic polymer 
Eudragit® FS 30 D and the polysaccharide chondroitin 
sulphate, when combined, may form films that are 
candidates for use in the coating of modified drug 
delivery systems especially due to the synergism between 
pH dependence and specific biodegradability by the 
colonic microbiota. The analysis using FTIR revealed 
no occurrence of a chemical interaction between the 
polymers, since a displacement and/or an appearance of 
new bands, that would characterize changes in the chemical 
FIGURE 3 - Raman spectra of the EFS 100:00 CS, EFS 95:05 CS, EFS 90:10 CS and EFS 80:20 CS composition films. Characteristic 
peak of CS at 1063 cm-1, characteristic of symmetric stretching of the grouping SO3
–.
FIGURE 4 - Swelling index (Sw%) of the EFS 100:00 CS, EFS 95:05 CS, EFS 90:10 CS and EFS 80:20 CS composition films in 
the simulated gastric fluid (SGF; pH 1.2) and simulated intestinal fluid (SIF; pH 6.8), (n=3). 
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FIGURE 5 - WVT in function of the composition of polymeric films. Eudragit® FS 30 D (EFS) associated with different 
concentrations of chondroitin sulfate (CS), (n=3). 
FIGURE 6 - Micrographs of dried isolated films and after swelling for 60 minutes in SGF and SIF: Eudragit® FS 30 D control, 
Eudragit® FS 30 D associated with chondroitin sulfate at an EFS 90:10 CS concentration. 
structure of the components, was not observed. This result 
corroborates that obtained by Raman spectroscopy, since 
the emergence or the extinction of Raman peaks was not 
identified. EFS 90:10 CS composite films were the most 
suitable for the development of coatings of modified 
drug delivery systems considering the characteristics of 
hydration and permeability of the various combinations 
tested. 
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